<p>隨着全球市場對經濟數據和地緣政治發展的反應各異，亞洲股市表現出韌性，中國和日本的指數在國內需求強勁和人工智能驅動的樂觀情緒中錄得上漲。在這種環境下，識別被低估的股票需要關注那些儘管面臨更廣泛市場不確定性，但仍展現出強大基本面和增長潛力的公司。</p>
<h3>基於現金流的亞洲十大被低估股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>當前價格</strong></td>
<td><strong>公允價值（估算）</strong></td>
<td><strong>折扣（估算）</strong></td>
</tr>
<tr>
<td>Yurtec (TSE:1934)</td>
<td>¥2498.00</td>
<td>¥4969.75</td>
<td>49.7%</td>
</tr>
<tr>
<td>TOKYO BASELtd (TSE:3415)</td>
<td>¥376.00</td>
<td>¥751.82</td>
<td>50%</td>
</tr>
<tr>
<td>SkyCity Entertainment Group (NZSE:SKC)</td>
<td>NZ$0.63</td>
<td>NZ$1.23</td>
<td>48.9%</td>
</tr>
<tr>
<td>Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990)</td>
<td>HK$449.20</td>
<td>HK$898.30</td>
<td>50%</td>
</tr>
<tr>
<td>Shenzhen Dynanonic (SZSE:300769)</td>
<td>CN¥80.29</td>
<td>CN¥156.46</td>
<td>48.7%</td>
</tr>
<tr>
<td>Plus Alpha ConsultingLtd (TSE:4071)</td>
<td>¥2339.00</td>
<td>¥4672.72</td>
<td>49.9%</td>
</tr>
<tr>
<td>Intco Medical Technology (SZSE:300677)</td>
<td>CN¥51.75</td>
<td>CN¥100.82</td>
<td>48.7%</td>
</tr>
<tr>
<td>Info-Tech Systems (SGX:ITS)</td>
<td>SGD0.98</td>
<td>SGD1.92</td>
<td>49%</td>
</tr>
<tr>
<td>Horizon Robotics (SEHK:9660)</td>
<td>HK$6.87</td>
<td>HK$13.54</td>
<td>49.2%</td>
</tr>
<tr>
<td>Beijing Luzhu Biotechnology (SEHK:2480)</td>
<td>HK$20.04</td>
<td>HK$39.19</td>
<td>48.9%</td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們基於現金流的 204 只被低估亞洲股票的完整列表。</p>
<p>我們將從我們的篩選結果中選取一些進行分析。</p>
<h2>RFHIC (KOSDAQ:A218410)</h2>
<p><strong>概述：</strong> RFHIC 公司設計和製造無線基礎設施、商業和軍事雷達以及射頻能源應用的射頻和微波組件，市值為 2.64 萬億韓元。</p>
<p><strong>運營：</strong> 公司的收入來源包括無線基礎設施、商業和軍事雷達以及射頻能源應用，服務於國內和國際市場。</p>
<p><strong>公允價值折扣估算：</strong> 24%</p>
<p>RFHIC 的交易價格為 104,000 韓元，顯著低於其估算的未來現金流價值 136,754.05 韓元，表明潛在的低估。儘管股價波動和利潤率從 22.3% 下降至 15.4%，但去年盈利增長了 11.7%，預計未來三年將以 29.43% 的年率顯著增長，超過韓國市場 13.6% 的收入增長率。</p>
<ul>
<li>我們最近的增長報告提供了對 RFHIC 商業前景的樂觀預測。</li>
<li>點擊這裏訪問我們的完整資產負債表健康報告，以瞭解 RFHIC 的動態。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8d35b4bb-9ac3-4df3-8886-b943244bee99/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8d35b4bb-9ac3-4df3-8886-b943244bee99/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>KOSDAQ:A218410 截至 2026 年 5 月的折現現金流</p>
<h2>GKG Precision Machine (SZSE:301338)</h2>
<p><strong>概述：</strong> GKG Precision Machine 有限公司在中國和國際上提供精密自動化設備，市值為 213.8 億人民幣。</p>
<p><strong>運營：</strong> GKG Precision Machine 有限公司通過提供精密自動化設備在國內和國際市場上產生收入。</p>
<p><strong>公允價值折扣估算：</strong> 11%</p>
<p>GKG Precision Machine 的交易價格為 200.95 人民幣，低於其估算的未來現金流價值 225.81 人民幣，表明潛在的低估。該公司報告了 2026 年第一季度強勁的業績，銷售額為 3.3965 億人民幣，淨收入為 6498 萬人民幣，反映出顯著的同比增長。儘管股價波動，去年盈利增長了 135.1%，預計未來三年將以 34.36% 的年率顯著增長，超出市場預期。</p>
<ul>
<li>我們的 GKG Precision Machine 增長報告中的分析暗示未來財務表現將強勁。</li>
<li>點擊探索我們在 GKG Precision Machine 資產負債表健康報告中的詳細發現。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f983ee38-85a1-44d1-8078-fc07d059c0f7/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f983ee38-85a1-44d1-8078-fc07d059c0f7/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>SZSE:301338 截至 2026 年 5 月的折現現金流</p>
<h2>Nippon Chemi-Con (TSE:6997)</h2>
<p><strong>概述：</strong> Nippon Chemi-Con 公司涉及鋁電容器和其他電容器、精密機械組件及電子設備的製造和銷售，業務遍及日本、中國、美洲、歐洲及國際市場，市值為 763.9 億日元。</p>
<p><strong>運營：</strong> 公司的收入主要來自其電容器部門，產生了 1272 億日元的收入。</p>
<p><strong>公允價值折扣估算：</strong> 45.9%</p>
<p>Nippon Chemi-Con 的交易價格為 3170 日元，顯著低於其估算的未來現金流價值 5864.2 日元。儘管去年盈利增長了 45.3%，預計年利潤將增加 52%，但利息支付未能得到盈利的良好覆蓋。該公司最近宣佈通過向日本開發銀行發行優先股籌集 90 億日元的私募，增加了在股價波動中的財務靈活性。</p>
<ul>
<li>根據我們最近的增長報告，Nippon Chemi-Con 的財務表現可能會超過當前水平。</li>
<li>點擊這裏閲讀 Nippon Chemi-Con 的資產負債表健康報告，獲取深入的視角。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/315324ed-d0c8-4ff1-baae-94405139c1a7/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/315324ed-d0c8-4ff1-baae-94405139c1a7/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>TSE:6997 截至 2026 年 5 月的折現現金流</p>
<h2>將想法轉化為行動</h2>
<ul>
<li>在這裏調查我們基於現金流的 204 只被低估亞洲股票的完整陣容。</li>
<li>你是否已經將投資組合多樣化到這些公司？利用 Simply Wall St 的投資組合功能，密切關注影響你投資的市場動態。</li>
<li>使用 Simply Wall St 提升你的投資組合，這是尋求全球市場覆蓋的投資者的終極應用。</li>
</ul>
<h2>想探索一些替代方案嗎？</h2>
<ul>
<li>探索尚未獲得顯著分析師關注的高表現小型公司。</li>
<li>通過穩健的分紅支付者來多樣化您的投資組合，以應對潛在的市場波動。</li>
<li>充實您的投資組合，選擇那些顯示出強勁增長潛力的公司，這些公司得到了分析師和管理層的樂觀展望支持。</li>
</ul>
<p><em>這篇文章來自 Simply Wall St，內容具有一般性。<strong>我們基於歷史數據和分析師預測提供評論，採用無偏見的方法，我們的文章並不構成財務建議。它不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。</strong> 我們旨在為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
<h3><strong>新功能：</strong> 在一個地方管理您的所有股票投資組合</h3>
<p>我們為股票投資者創建了 <strong>終極投資組合助手</strong>，<strong>而且是免費的。</strong></p>
<p>• 連接無限數量的投資組合，並以一種貨幣查看您的總額</p>
<p>• 通過電子郵件或手機接收新的警告信號或風險提示</p>
<p>• 跟蹤您股票的公允價值</p>
<p>免費試用演示投資組合</p>

6997

3415

1934

<p>亞洲股市在全球市場波動中表現出韌性，重點關注被低估的股票。被識別的關鍵公司包括 Yurtec、TOKYO BASE 和 Nippon Chemi-Con，這些公司的交易價格均低於其估計的公允價值。例如，Nippon Chemi-Con 的交易價格為¥3,170，遠低於其估計價值¥5,864.2，儘管其盈利增長強勁。分析師建議，這些股票在更廣泛的市場不確定性中可能提供增長潛力。文章強調了在當前經濟環境中，強勁基本面在識別投資機會中的重要性</p>

<p>As global markets experience varied reactions to economic data and geopolitical developments, Asian equities have shown resilience, with Chinese and Japanese indices posting gains amid positive domestic demand and AI-driven optimism. In this environment, identifying undervalued stocks requires a focus on companies that demonstrate strong fundamentals and potential for growth despite broader market uncertainties.</p>
<div class="lb-trans"><p>隨着全球市場對經濟數據和地緣政治發展的反應各異，亞洲股市表現出韌性，中國和日本的指數在國內需求強勁和人工智能驅動的樂觀情緒中錄得上漲。在這種環境下，識別被低估的股票需要關注那些儘管面臨更廣泛市場不確定性，但仍展現出強大基本面和增長潛力的公司。</p>
</div><h3>Top 10 Undervalued Stocks Based On Cash Flows In Asia</h3>
<div class="lb-trans"><h3>基於現金流的亞洲十大被低估股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Current Price</strong></td>
<td><strong>Fair Value (Est)</strong></td>
<td><strong>Discount (Est)</strong></td>
</tr>
<tr>
<td>Yurtec (TSE:1934)</td>
<td>¥2498.00</td>
<td>¥4969.75</td>
<td>49.7%</td>
</tr>
<tr>
<td>TOKYO BASELtd (TSE:3415)</td>
<td>¥376.00</td>
<td>¥751.82</td>
<td>50%</td>
</tr>
<tr>
<td>SkyCity Entertainment Group (NZSE:SKC)</td>
<td>NZ$0.63</td>
<td>NZ$1.23</td>
<td>48.9%</td>
</tr>
<tr>
<td>Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990)</td>
<td>HK$449.20</td>
<td>HK$898.30</td>
<td>50%</td>
</tr>
<tr>
<td>Shenzhen Dynanonic (SZSE:300769)</td>
<td>CN¥80.29</td>
<td>CN¥156.46</td>
<td>48.7%</td>
</tr>
<tr>
<td>Plus Alpha ConsultingLtd (TSE:4071)</td>
<td>¥2339.00</td>
<td>¥4672.72</td>
<td>49.9%</td>
</tr>
<tr>
<td>Intco Medical Technology (SZSE:300677)</td>
<td>CN¥51.75</td>
<td>CN¥100.82</td>
<td>48.7%</td>
</tr>
<tr>
<td>Info-Tech Systems (SGX:ITS)</td>
<td>SGD0.98</td>
<td>SGD1.92</td>
<td>49%</td>
</tr>
<tr>
<td>Horizon Robotics (SEHK:9660)</td>
<td>HK$6.87</td>
<td>HK$13.54</td>
<td>49.2%</td>
</tr>
<tr>
<td>Beijing Luzhu Biotechnology (SEHK:2480)</td>
<td>HK$20.04</td>
<td>HK$39.19</td>
<td>48.9%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>當前價格</strong></td>
<td><strong>公允價值（估算）</strong></td>
<td><strong>折扣（估算）</strong></td>
</tr>
<tr>
<td>Yurtec (TSE:1934)</td>
<td>¥2498.00</td>
<td>¥4969.75</td>
<td>49.7%</td>
</tr>
<tr>
<td>TOKYO BASELtd (TSE:3415)</td>
<td>¥376.00</td>
<td>¥751.82</td>
<td>50%</td>
</tr>
<tr>
<td>SkyCity Entertainment Group (NZSE:SKC)</td>
<td>NZ$0.63</td>
<td>NZ$1.23</td>
<td>48.9%</td>
</tr>
<tr>
<td>Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990)</td>
<td>HK$449.20</td>
<td>HK$898.30</td>
<td>50%</td>
</tr>
<tr>
<td>Shenzhen Dynanonic (SZSE:300769)</td>
<td>CN¥80.29</td>
<td>CN¥156.46</td>
<td>48.7%</td>
</tr>
<tr>
<td>Plus Alpha ConsultingLtd (TSE:4071)</td>
<td>¥2339.00</td>
<td>¥4672.72</td>
<td>49.9%</td>
</tr>
<tr>
<td>Intco Medical Technology (SZSE:300677)</td>
<td>CN¥51.75</td>
<td>CN¥100.82</td>
<td>48.7%</td>
</tr>
<tr>
<td>Info-Tech Systems (SGX:ITS)</td>
<td>SGD0.98</td>
<td>SGD1.92</td>
<td>49%</td>
</tr>
<tr>
<td>Horizon Robotics (SEHK:9660)</td>
<td>HK$6.87</td>
<td>HK$13.54</td>
<td>49.2%</td>
</tr>
<tr>
<td>Beijing Luzhu Biotechnology (SEHK:2480)</td>
<td>HK$20.04</td>
<td>HK$39.19</td>
<td>48.9%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 204 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們基於現金流的 204 只被低估亞洲股票的完整列表。</p>
</div><p>We'll examine a selection from our screener results.</p>
<div class="lb-trans"><p>我們將從我們的篩選結果中選取一些進行分析。</p>
</div><h2>RFHIC (KOSDAQ:A218410)</h2>
<div class="lb-trans"><h2>RFHIC (KOSDAQ:A218410)</h2>
</div><p><strong>Overview:</strong> RFHIC Corporation designs and manufactures RF and microwave components for wireless infrastructure, commercial and military radar, and RF energy applications globally, with a market cap of ₩2.64 trillion.</p>
<div class="lb-trans"><p><strong>概述：</strong> RFHIC 公司設計和製造無線基礎設施、商業和軍事雷達以及射頻能源應用的射頻和微波組件，市值為 2.64 萬億韓元。</p>
</div><p><strong>Operations:</strong> The company's revenue segments include wireless infrastructure, commercial and military radar, and RF energy applications, serving both domestic and international markets.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入來源包括無線基礎設施、商業和軍事雷達以及射頻能源應用，服務於國內和國際市場。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 24%</p>
<div class="lb-trans"><p><strong>公允價值折扣估算：</strong> 24%</p>
</div><p>RFHIC is trading at ₩104,000, significantly below its estimated future cash flow value of ₩136,754.05, indicating potential undervaluation. Despite a volatile share price and declining profit margins from 22.3% to 15.4%, earnings grew by 11.7% last year and are forecast to grow significantly at 29.43% annually over the next three years, outpacing the KR market's revenue growth rate of 13.6%.</p>
<div class="lb-trans"><p>RFHIC 的交易價格為 104,000 韓元，顯著低於其估算的未來現金流價值 136,754.05 韓元，表明潛在的低估。儘管股價波動和利潤率從 22.3% 下降至 15.4%，但去年盈利增長了 11.7%，預計未來三年將以 29.43% 的年率顯著增長，超過韓國市場 13.6% 的收入增長率。</p>
</div><ul>
<li>Insights from our recent growth report point to a promising forecast for RFHIC's business outlook.</li>
<li>Click here and access our complete balance sheet health report to understand the dynamics of RFHIC.</li>
</ul>
<div class="lb-trans"><ul>
<li>我們最近的增長報告提供了對 RFHIC 商業前景的樂觀預測。</li>
<li>點擊這裏訪問我們的完整資產負債表健康報告，以瞭解 RFHIC 的動態。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8d35b4bb-9ac3-4df3-8886-b943244bee99/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/8d35b4bb-9ac3-4df3-8886-b943244bee99/chart/dcf?theme=light"/></p>
<p>KOSDAQ:A218410 Discounted Cash Flow as at May 2026</p>
<div class="lb-trans"><p>KOSDAQ:A218410 截至 2026 年 5 月的折現現金流</p>
</div><h2>GKG Precision Machine (SZSE:301338)</h2>
<div class="lb-trans"><h2>GKG Precision Machine (SZSE:301338)</h2>
</div><p><strong>Overview:</strong> GKG Precision Machine Co., Ltd. provides precision automation equipment both in China and internationally, with a market cap of CN¥21.38 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> GKG Precision Machine 有限公司在中國和國際上提供精密自動化設備，市值為 213.8 億人民幣。</p>
</div><p><strong>Operations:</strong> GKG Precision Machine Co., Ltd. generates revenue through the provision of precision automation equipment across domestic and international markets.</p>
<div class="lb-trans"><p><strong>運營：</strong> GKG Precision Machine 有限公司通過提供精密自動化設備在國內和國際市場上產生收入。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 11%</p>
<div class="lb-trans"><p><strong>公允價值折扣估算：</strong> 11%</p>
</div><p>GKG Precision Machine, trading at CN¥200.95, is below its estimated future cash flow value of CN¥225.81, suggesting potential undervaluation. The company reported strong Q1 2026 results with sales of CN¥339.65 million and net income of CN¥64.98 million, reflecting significant year-over-year growth. Despite a volatile share price, earnings grew by 135.1% last year and are projected to grow significantly at 34.36% annually over the next three years, surpassing market expectations.</p>
<div class="lb-trans"><p>GKG Precision Machine 的交易價格為 200.95 人民幣，低於其估算的未來現金流價值 225.81 人民幣，表明潛在的低估。該公司報告了 2026 年第一季度強勁的業績，銷售額為 3.3965 億人民幣，淨收入為 6498 萬人民幣，反映出顯著的同比增長。儘管股價波動，去年盈利增長了 135.1%，預計未來三年將以 34.36% 的年率顯著增長，超出市場預期。</p>
</div><ul>
<li>The analysis detailed in our GKG Precision Machine growth report hints at robust future financial performance.</li>
<li>Click to explore a detailed breakdown of our findings in GKG Precision Machine's balance sheet health report.</li>
</ul>
<div class="lb-trans"><ul>
<li>我們的 GKG Precision Machine 增長報告中的分析暗示未來財務表現將強勁。</li>
<li>點擊探索我們在 GKG Precision Machine 資產負債表健康報告中的詳細發現。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f983ee38-85a1-44d1-8078-fc07d059c0f7/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/f983ee38-85a1-44d1-8078-fc07d059c0f7/chart/dcf?theme=light"/></p>
<p>SZSE:301338 Discounted Cash Flow as at May 2026</p>
<div class="lb-trans"><p>SZSE:301338 截至 2026 年 5 月的折現現金流</p>
</div><h2>Nippon Chemi-Con (TSE:6997)</h2>
<div class="lb-trans"><h2>Nippon Chemi-Con (TSE:6997)</h2>
</div><p><strong>Overview:</strong> Nippon Chemi-Con Corporation is involved in the manufacturing and sale of aluminum and other capacitors, precision mechanical components, and electronics equipment across Japan, China, the Americas, Europe, and internationally with a market cap of ¥76.39 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Nippon Chemi-Con 公司涉及鋁電容器和其他電容器、精密機械組件及電子設備的製造和銷售，業務遍及日本、中國、美洲、歐洲及國際市場，市值為 763.9 億日元。</p>
</div><p><strong>Operations:</strong> The company's revenue primarily comes from its capacitors segment, which generated ¥127.20 billion.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入主要來自其電容器部門，產生了 1272 億日元的收入。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 45.9%</p>
<div class="lb-trans"><p><strong>公允價值折扣估算：</strong> 45.9%</p>
</div><p>Nippon Chemi-Con, trading at ¥3,170, is significantly undervalued relative to its estimated future cash flow value of ¥5,864.2. Despite earnings growth of 45.3% last year and a projected annual profit increase of 52%, interest payments are not well covered by earnings. The company recently announced a private placement raising ¥9 billion from preferred shares issuance with the Development Bank of Japan Inc., adding financial flexibility amid share price volatility.</p>
<div class="lb-trans"><p>Nippon Chemi-Con 的交易價格為 3170 日元，顯著低於其估算的未來現金流價值 5864.2 日元。儘管去年盈利增長了 45.3%，預計年利潤將增加 52%，但利息支付未能得到盈利的良好覆蓋。該公司最近宣佈通過向日本開發銀行發行優先股籌集 90 億日元的私募，增加了在股價波動中的財務靈活性。</p>
</div><ul>
<li>In light of our recent growth report, it seems possible that Nippon Chemi-Con's financial performance will exceed current levels.</li>
<li>Get an in-depth perspective on Nippon Chemi-Con's balance sheet by reading our health report here.</li>
</ul>
<div class="lb-trans"><ul>
<li>根據我們最近的增長報告，Nippon Chemi-Con 的財務表現可能會超過當前水平。</li>
<li>點擊這裏閲讀 Nippon Chemi-Con 的資產負債表健康報告，獲取深入的視角。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/315324ed-d0c8-4ff1-baae-94405139c1a7/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/315324ed-d0c8-4ff1-baae-94405139c1a7/chart/dcf?theme=light"/></p>
<p>TSE:6997 Discounted Cash Flow as at May 2026</p>
<div class="lb-trans"><p>TSE:6997 截至 2026 年 5 月的折現現金流</p>
</div><h2>Turning Ideas Into Actions</h2>
<div class="lb-trans"><h2>將想法轉化為行動</h2>
</div><ul>
<li>Investigate our full lineup of 204 Undervalued Asian Stocks Based On Cash Flows right here.</li>
<li>Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.</li>
<li>Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.</li>
</ul>
<div class="lb-trans"><ul>
<li>在這裏調查我們基於現金流的 204 只被低估亞洲股票的完整陣容。</li>
<li>你是否已經將投資組合多樣化到這些公司？利用 Simply Wall St 的投資組合功能，密切關注影響你投資的市場動態。</li>
<li>使用 Simply Wall St 提升你的投資組合，這是尋求全球市場覆蓋的投資者的終極應用。</li>
</ul>
</div><h2>Want To Explore Some Alternatives?</h2>
<div class="lb-trans"><h2>想探索一些替代方案嗎？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未獲得顯著分析師關注的高表現小型公司。</li>
<li>通過穩健的分紅支付者來多樣化您的投資組合，以應對潛在的市場波動。</li>
<li>充實您的投資組合，選擇那些顯示出強勁增長潛力的公司，這些公司得到了分析師和管理層的樂觀展望支持。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation.</strong> We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>這篇文章來自 Simply Wall St，內容具有一般性。<strong>我們基於歷史數據和分析師預測提供評論，採用無偏見的方法，我們的文章並不構成財務建議。它不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。</strong> 我們旨在為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
</div><h3><strong>New:</strong> Manage All Your Stock Portfolios in One Place</h3>
<div class="lb-trans"><h3><strong>新功能：</strong> 在一個地方管理您的所有股票投資組合</h3>
</div><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p>
<div class="lb-trans"><p>我們為股票投資者創建了 <strong>終極投資組合助手</strong>，<strong>而且是免費的。</strong></p>
</div><p>• Connect an unlimited number of Portfolios and see your total in one currency</p>
<div class="lb-trans"><p>• 連接無限數量的投資組合，並以一種貨幣查看您的總額</p>
</div><p>• Be alerted to new Warning Signs or Risks via email or mobile</p>
<div class="lb-trans"><p>• 通過電子郵件或手機接收新的警告信號或風險提示</p>
</div><p>• Track the Fair Value of your stocks</p>
<div class="lb-trans"><p>• 跟蹤您股票的公允價值</p>
</div><p>Try a Demo Portfolio for Free</p>
<div class="lb-trans"><p>免費試用演示投資組合</p>
</div>

2026 年 5 月可能低於估值進行交易的亞洲股票